A study of platelet functions, some hemostatic and fibrinolytic parameters in relation to serotonin in hemodialyzed patients under erythropoietin therapy
- 15 January 1995
- journal article
- clinical trial
- Published by Elsevier in Thrombosis Research
- Vol. 77 (2) , 133-143
- https://doi.org/10.1016/0049-3848(95)91619-v
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Defects in platelet adhesion and aggregate formation in uremic bleeding disorder can be attributed to factors in plasma.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Recombinant human erythropoietin shortens the uraemic bleeding time without causing intravascular haemostatic activationThrombosis Research, 1990
- Correction of Anaemia of Chronic Renal Failure with Recombinant Human Erythropoietin: Safety and Efficacy of One Year's Treatment in a European Multicentre Study of 150 Haemodialysis-Dependent Patients*Nephrology Dialysis Transplantation, 1989
- Blood Rheology and Hypertension in Hemodialysis Patients Treated with ErythropoietinAmerican Journal of Nephrology, 1988
- IMPROVEMENT IN THE HAEMOSTATIC DEFECT OF URAEMIA AFTER TREATMENT WITH RECOMBINANT HUMAN ERYTHROPOIETINThe Lancet, 1987
- Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis.BMJ, 1987
- Platelet-vessel wall interactions in hemostasis: Implication of 5-hydroxytryptamineInflammation Research, 1984
- Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodiesAnalytical Biochemistry, 1966
- The aggregation of blood plateletsThe Journal of Physiology, 1963
- AN EVALUATION OF THE EUGLOBULIN METHOD FOR THE DETERMINATION OF FIBRINOLYSISJournal of Clinical Pathology, 1959